EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Evidence on SGLT2 Inhibitors’ Efficacy in Older and Frail Patients

Anna Kochanowska iD, Artur Mamcarz, Marcin Wełnicki iD

Journal of Clinical Medicine · 14.03.2026 · 15 (6) · 2219

DOI: 10.3390/jcm15062219 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.03.2026. Verfasst von Anna Kochanowska und 2 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Internal Medicine and Cardiology, Medical University of Warsaw, 04-749 Warsaw, Poland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have proven their favorable cardiovascular and nephroprotective benefits in large randomized-controlled trials (RCTs). Given that older adults constitute a substantial part of patients with type 2 diabetes mellitus (T2DM), heart failure (HF), and chronic kidney disease (CKD), they are the primary target population for SGLT2 inhibitor therapy. However, their representation in clinical trials remains low and it does not reflect the real-life heterogeneity of this group of patients. As chronological age alone does not adequately reflect the biological age, it is important to evaluate older adults using a multidimensional approach, particularly with regard to frailty. This review aims to summarize and critically appraise the available evidence regarding the efficacy of SGLT2 inhibitors in older and frail adults, with a focus on age-specific outcomes, such as cognitive outcomes, risk of sarcopenia, functional activity and current gaps in evidence related to frailty.

Schlagwörter

Stichwörter der Autor:innen

SGLT2 inhibitorsefficacyfrailtyolder adults

Autor:innen und Institutionen

  • 3rd Department of Internal Medicine and Cardiology, Medical University of Warsaw, 04-749 Warsaw, Poland.

ORCID-Profile: Anna Kochanowska, Marcin Wełnicki

Zitieren

APA

Kochanowska, A., Mamcarz, A., & Wełnicki, M. (2026). Evidence on SGLT2 Inhibitors’ Efficacy in Older and Frail Patients. Journal of Clinical Medicine, 15(6), 2219. https://doi.org/10.3390/jcm15062219

Vancouver

Kochanowska A, Mamcarz A, Wełnicki M. Evidence on SGLT2 Inhibitors’ Efficacy in Older and Frail Patients. Journal of Clinical Medicine. 2026;15(6):2219. doi:10.3390/jcm15062219

BibTeX
@article{Kochanowska2026,
  author = {Kochanowska, Anna and Mamcarz, Artur and Wełnicki, Marcin},
  title = {Evidence on SGLT2 Inhibitors’ Efficacy in Older and Frail Patients},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {2219},
  doi = {10.3390/jcm15062219}
}
Kostenlos starten →